According to Recursion Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $43.87 M. In 2022 the company made a revenue of $39.68 M an increase over the years 2021 revenue that were of $10 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $43.87 M | 10.57% |
2022 | $39.68 M | 296.81% |
2021 | $10 M | 193% |
2020 | $3.41 M |